Clinical Trials

Immune-Checkpoint Inhibitor-Induced Arthritis

Synovial Tissue and Peripheral Blood Phenotypes in Immune Checkpoint Inhibitor–Induced Arthritis

• Investigator: Bobby Han, MD

• Study Coordinator: Jennifer Schaeffer, CCRC

Still’s Disease with Macrophage Activation Syndrome

NI-0501-14: A Two-Cohort, Open-Label, Single Arm, Multicenter Study to Evaluate Efficacy, Safety and Tolerability, Pharmacokinetics and Pharmacodynamics, of Emapalumab in Children and Adults with Macrophage Activation Syndrome (MAS) in Still’s Disease or With MAS in Systemic Lupus Erythematous

• Investigator: Bobby Han, MD

• Study Coordinator: Jennifer Schaeffer, CCRC

Active Inflammatory Arthritis

Development and Validation of Applying Thermal Imaging as An Adjunct Tool to Augment Physician’s Assessment in The Telehealth Setting

• Investigator: Bobby Han, MD

• Study Coordinator: Jennifer Schaeffer, CCRC

System Lupus Erythematosus

SL0043: A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants with Moderately to Severely Active Systemic Lupus Erythematosus

• Investigator: Bobby Han, MD

• Study Coordinator: Jennifer Schaeffer, CCRC

Cutaneous

Dermatomyositis

CUDM001: An Open-Label Pilot Study to Evaluate the Efficacy and Safety of Baricitinib in Subjects with Cutaneous Dermatomyositis

• Investigators: Dr. Keith Elkon & Dr. Andrea Kalus

• Study Coordinator: Jennifer Schaeffer, CCRC

Open to All

Rheumatic Disease Biorepository & Patient Registry

• Investigators: Dr. Keith Elkon & Dr. Sarah Chung
• Study Coordinator: Cara Currier